Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

During a Merck Serono-sponsored satellite symposium at the 29th Annual European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) conference, presenters shared research regarding ...

Multiple sclerosis (MS) is a complex and unpredictable disease that affects the central nervous system. It is the most common neurologic disease of young adults, usually diagnosed between the ages of ...

Multiple sclerosis (MS) is a complex disease with a wide range of clinical manifestations. Current disease-modifying drugs (DMDs) are effective, but they are associated with effects that may ...

pregnant While it is now well-established that having MS should not limit patients' reproductive choices, this was not always the case. Multiple sclerosis (MS) affects approximately 3 times as many ...

Keeping up with scientific advances and practice changes can be one the biggest challenges in managing a complex disease like multiple sclerosis (MS). The Consortium of Multiple Sclerosis Centers ...

Not sure if your MS management plan is up-to-date? Take this quiz to find out. When living with a chronic, progressive disease like MS, it’s important that you’re aware of how your symptoms affect ...

Multiple sclerosis (MS) is an insidious disease. Patients suffer because their immune system is attacking their own nerve fibres, which inhibits the transmission of nerve signals. People with MS ...

NEW YORK, Sept. 11, 2025 /PRNewswire/ -- Great Place To Work® and Fortune magazine have selected the International Multiple Sclerosis Management Practice (IMSMP) for the 2025 Fortune Best Workplaces ...